Discover 1,294 paid clinical trials in Surprise, Arizona. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 1,294
A Study of Amivantamab in Combination With Lazertinib, or Amivantamab in Combination With Platinum-Based Chemotherapy, for Common Epidermal Growth Factor Receptor (EGFR)-Mutated Locally Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC)
for
Carcinoma, Non-Small-Cell Lung
Location: Goodyear AZ, La Jolla CA, Corona CA, Upland CA,
Sponsor: Janssen Research & Development, LLC
Sex: All
Age: 18+
Code: NCT06667076
Phase 2, Recruiting
A Study Evaluating the Prophylactic Use of Tocilizumab to Prevent Cytokine Release Syndrome With Ramantamig Administration in Participants With Relapsed/Refractory Multiple Myeloma
for
Multiple Myeloma
Location: Goodyear AZ, Irvine CA, Beverly Hills CA, Denver CO,
Sponsor: Janssen Research & Development, LLC
Sex: All
Age: 18+
Code: NCT07589634
Phase 2, Recruiting
REGN15505 (PSMAx4-1BB) Alone or in Combination With Cemiplimab or REGN4336 (PSMAxCD3) in Adult Patients With Metastatic Castration-Resistant Prostate Cancer and Clear Cell Renal Cell Carcinoma
for
Metastatic Castration-Resistant Prostate Cancer (mCRPC),
Location: Goodyear AZ, Duarte CA, Houston TX, St Louis MO,
Sponsor: Regeneron Pharmaceuticals
Sex: All
Age: 18+
Code: NCT07594106
Phase 1, Phase 2, Recruiting
BGB-43395 Plus Letrozole Versus CDK4/6i Plus Letrozole for Patients With Advanced or Metastatic HR+/HER2- Breast Cancer Who Have Not Received Prior Treatment for Advanced or Metastatic Disease
for
HR+/HER2- Breast Cancer
Location: Goodyear AZ, Chandler AZ, Bullhead City AZ,
Sponsor: BeOne Medicines
Sex: All
Age: 18+
Code: NCT07492641
Phase 3, Recruiting
Study of Tarlatamab + ZL-1310 +/- Anti-programmed Death Ligand 1 (Anti-PD-L1) in Small Cell Lung Cancer (SCLC)
for
Small Cell Lung Cancer
Location: Goodyear AZ, Memphis TN, Saint Paul MN, Zion IL,
Sponsor: Amgen
Sex: All
Age: 18 - 70+
Code: NCT07531095
Phase 1, Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
A Study to Investigate Ubamatamab With and Without Marlotamig (REGN7075) in Adult Participants With Advanced/Metastatic Non-Small Cell Lung Cancer (NSCLC)
for
Non Small Cell Lung Cancer, Advanced Non Small Cell Lung Cancer,
Location: Goodyear AZ, Irvine CA, Temple TX, Portland OR,
Sponsor: Regeneron Pharmaceuticals
Sex: All
Age: 18+
Code: NCT07154290
Phase 2, Recruiting
Asparaginase Erwinia Chrysanthemi With Chemotherapy for the Treatment of High-Risk Adults With Newly Diagnosed Acute Lymphoblastic Leukemia or Lymphoblastic Lymphoma
for
B Acute Lymphoblastic Leukemia, Philadelphia Chromosome Negative,
Location: Phoenix AZ, Irvine CA, Duarte CA, Chicago IL
Sponsor: City of Hope Medical Center
Sex: All
Age: 18 - 54
Code: NCT06918431
Phase 2, Recruiting
A Study of Xaluritamig Plus Abiraterone Versus Investigator's Choice in Participants With Chemotherapy-naïve Metastatic Castration-resistant Prostate Cancer
for
Metastatic Castration-resistant Prostate Cancer
Location: Goodyear AZ, Tucson AZ, Orange CA, Fullerton CA,
Sponsor: Amgen
Sex: Male
Age: 18+
Code: NCT07213674
Phase 3, Recruiting
A Study of Bleximenib, Venetoclax and Azacitidine For Treatment of Participants With Newly Diagnosed Acute Myeloid Leukemia (AML)
for
Leukemia, Myeloid, Acute
Location: Goodyear AZ, Jupiter FL, Tucson AZ, Duarte CA,
Sponsor: Janssen Research & Development, LLC
Sex: All
Age: 18+
Code: NCT06852222
Phase 3, Recruiting
TAPUR: Testing the Use of Food and Drug Administration (FDA) Approved Drugs That Target a Specific Abnormality in a Tumor Gene in People With Advanced Stage Cancer
Location: Avondale AZ, Mesa AZ, Houston TX, Rochester MN,
Sponsor: VDI Technologies
Sex: All
Age: 18+
Code: NCT06641362
Recruiting
Reducing Adverse Vascular Outcomes With Factor XI Inhibition in Adult Participants With Peripheral Artery Disease
for
Peripheral Artery Disease (PAD)
Location: Avondale AZ, Los Angeles CA, West Hills CA, Oxnard CA,
Sponsor: Regeneron Pharmaceuticals
Sex: All
Age: 18+
Code: NCT07318610
Phase 3, Recruiting
A Phase 2, Randomized, Placebo Controlled, Multicenter, Masked Study to Evaluate the Efficacy, Safety, Tolerability, and Pharmacodynamics of Multidose APL 3007 in Combination With Syfovre/Pegcetacoplan (APL-2) in Patients Diagnosed With Geographic Atrophy Secondary to Age Related Macular Degeneratio
for
Geographic Atrophy Secondary to Age-related Macular Degeneration,
Location: Phoenix AZ, Scottsdale AZ, Mesa AZ, Gilbert AZ,
Sponsor: Apellis Pharmaceuticals, Inc.
Sex: All
Age: 60+
Code: NCT07215390
Phase 2, Recruiting
A Study Investigating Subcutaneously Administered Pozelimab in Combination With Cemdisiran or Cemdisiran Alone in Adult Participants With Geographic Atrophy
Location: Phoenix AZ, Scottsdale AZ, Chandler AZ, Tucson AZ,
Sponsor: Regeneron Pharmaceuticals
Sex: All
Age: 50 - 70+
Code: NCT06541704
Phase 3, Recruiting
New
Online Sleep Education for College Student's Sleep Health and Executive Functioning
for
Sleep, Executive Functioning, Sleep Hygiene, Health Literacy
Location: Phoenix AZ
Sponsor: Northern Arizona University
Sex: All
Age: 18+
Code: NCT07765849
Recruiting
A Global Study of Volrustomig (MEDI5752) for Participants With Unresected Locally Advanced Head and Neck Squamous Cell Carcinoma Following Definitive Concurrent Chemoradiotherapy
for
Locally Advanced Head and Neck Squamous Cell Carcinoma
Location: Phoenix AZ, Fountain Valley CA, Whittier CA,
Sponsor: AstraZeneca
Sex: All
Age: 18 - 70+
Code: NCT06129864
Phase 3, Recruiting
A Study to Investigate the Efficacy and Safety of Tezepelumab Compared With Placebo in Children 5 to < 12 Years Old With Severe Asthma
for
Asthma
Location: Phoenix AZ, San Diego CA, Long Beach CA,
Sponsor: AstraZeneca
Sex: All
Age: 5 - 11
Code: NCT06023589
Phase 3, Recruiting
A Study to Evaluate Effect of AZD6234 in Adult Participants With Type 2 Diabetes Mellitus and Obesity or Overweight
for
Obesity or Overweight, Diabetes Mellitus, Type 2
Location: Phoenix AZ, Gardena CA, Lincoln CA, Houston TX,